@xconomy.com 1 month ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com 2 months ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@techcrunch.com 1 year ago
All that glitters is not gold: How healthtech startups can achieve true value
@xconomy.com 1 year ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com 1 year ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way